玻璃体内注射贝伐单抗单独及联合光动力疗法治疗年龄相关性黄斑变性和息肉状脉络膜血管病变后的1年随访。 - Suppr | 超能文献

1 - year follow-up after intravitreal bevacizumab alone and in combination with photodynamic therapy for AMD and PCV.

作者信息

Forte Raimondo

出版信息

Acta Ophthalmol. 2011 Jun;89(4):e373. doi: 10.1111/j.1755-3768.2010.01991.x. Epub 2010 Oct 7.

DOI:10.1111/j.1755-3768.2010.01991.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

1 - year follow-up after intravitreal bevacizumab alone and in combination with photodynamic therapy for AMD and PCV.玻璃体内注射贝伐单抗单独及联合光动力疗法治疗年龄相关性黄斑变性和息肉状脉络膜血管病变后的1年随访。

Acta Ophthalmol. 2011 Jun;89(4):e373. doi: 10.1111/j.1755-3768.2010.01991.x. Epub 2010 Oct 7.

2

Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy.玻璃体内注射贝伐单抗与光动力疗法序贯治疗特发性息肉状脉络膜血管病变

Acta Ophthalmol. 2009 Nov;87(7):806-7. doi: 10.1111/j.1755-3768.2008.01330.x. Epub 2008 Aug 20.

3

Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.玻璃体内注射贝伐单抗联合光动力疗法治疗息肉状脉络膜血管病变的疗效。

Am J Ophthalmol. 2010 Jul;150(1):48-54.e1. doi: 10.1016/j.ajo.2010.02.008.

4

Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.光动力疗法联合玻璃体内血管内皮生长因子抗体注射治疗息肉状脉络膜血管病变。

Ophthalmologica. 2011;225(3):169-75. doi: 10.1159/000323811. Epub 2011 Jan 27.

5

Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.单纯光动力疗法或联合后Tenon 鞘曲安奈德或玻璃体腔内贝伐单抗治疗对吲哚菁绿血管造影脉络膜低荧光的影响。

Retina. 2010 Mar;30(3):495-502. doi: 10.1097/IAE.0b013e3181bcedbe.

6

Photodynamic therapy for polypoidal choroidal vasculopathy.息肉状脉络膜血管病变的光动力疗法。

Am J Ophthalmol. 2010 Nov;150(5):754-5; author reply 755. doi: 10.1016/j.ajo.2010.07.021.

7

Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.低强度光动力疗法联合玻璃体内贝伐单抗治疗息肉状脉络膜血管病变。

Am J Ophthalmol. 2012 May;153(5):873-882.e2. doi: 10.1016/j.ajo.2011.09.031. Epub 2012 Jan 20.

8

Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.眼内注射贝伐单抗治疗息肉状脉络膜血管病变的渗出性分支血管网。

Br J Ophthalmol. 2012 Mar;96(3):394-9. doi: 10.1136/bjo.2011.204123. Epub 2011 Jun 30.

9

Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapy.玻璃体内注射贝伐单抗和经Tenon 囊曲安奈德注射联合防治光动力疗法诱导脉络膜毛细血管闭塞的保护作用。

Ophthalmologica. 2010;224(5):267-73. doi: 10.1159/000287348. Epub 2010 Feb 25.

10

LOC387715/HTRA1 variants and the response to combined photodynamic therapy with intravitreal bevacizumab for polypoidal choroidal vasculopathy.LOC387715/HTRA1 变体与玻璃体内贝伐单抗联合光动力疗法治疗息肉状脉络膜血管病变的反应。

Retina. 2012 Feb;32(2):299-307. doi: 10.1097/IAE.0b013e318225290f.